Louis Manzo's Insider Trades & SAST Disclosures
Louis Manzo's most recent trade in Capricor Therapeutics Inc was a trade of 1,401 Common Stock done at an average price of $1.4 . Disclosure was reported to the exchange on Feb. 21, 2023.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Louis Manzo.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Capricor Therapeutics Inc | Louis V. Manzo | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.39 per share. | 21 Feb 2023 | 1,401 | 62,599 (1%) | 0% | 1.4 | 1,947 | Common Stock |
| Capricor Therapeutics Inc | Louis V. Manzo | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2023 | 1,401 | 0 | - | - | Stock Option (Right to Buy) | |
| Capricor Therapeutics Inc | Louis V. Manzo | Director | Sale or transfer of securities back to the company at price $ 4.31 per share. | 21 Feb 2023 | 452 | 62,147 (1%) | 0% | 4.3 | 1,948 | Common Stock |
| Capricor Therapeutics Inc | Louis V. Manzo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 37,770 | 37,770 | - | - | Stock Option (Right to Buy) | |
| Capricor Therapeutics Inc | Louis V. Manzo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 19,000 | 19,000 | - | - | Stock Option (Right to Buy) | |
| Capricor Therapeutics Inc | Louis V. Manzo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 7,120 | 7,120 | - | - | Stock Option (Right to Buy) | |
| Capricor Therapeutics Inc | Louis V. Manzo | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.39 per share. | 31 Mar 2022 | 27,904 | 27,904 (0%) | 0% | 1.4 | 38,787 | Common Stock |
| Capricor Therapeutics Inc | Louis V. Manzo | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2022 | 15,455 | 0 | - | - | Stock Option (Right to Buy) | |
| Capricor Therapeutics Inc | Louis V. Manzo | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2022 | 12,449 | 0 | - | - | Stock Option (Right to Buy) | |
| Capricor Therapeutics Inc | Louis V. Manzo | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.43 per share. | 31 Mar 2022 | 11,309 | 16,595 (0%) | 0% | 3.4 | 38,790 | Common Stock |
| Capricor Therapeutics Inc | Louis V. Manzo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 83,590 | 83,590 | - | - | Stock Option (Right to Buy) | |
| Capricor Therapeutics Inc | Louis V. Manzo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 72,066 | 72,066 | - | - | Stock Option (Right to Buy) | |
| Capricor Therapeutics Inc | Louis Manzo | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.70 per share. | 24 Sep 2020 | 8,299 | 44,603 (0%) | 0% | 3.7 | 30,706 | Common Stock |
| Capricor Therapeutics Inc | Louis Manzo | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Sep 2020 | 8,299 | 0 | - | - | Stock Option (Right to Buy) | |
| Capricor Therapeutics Inc | Louis Manzo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2020 | 83,000 | 83,000 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges